It has been reported that eriodictyol exerts inhibitory effects on cell proliferation, migration, as well as invasion of glioma cells via regulating PI3K/Akt/NF-κB signaling pathway [12]. The gene discussed is NFKB1; the disease is central nervous system cancer.